{"id":39351,"date":"2014-09-26T10:41:46","date_gmt":"2014-09-26T14:41:46","guid":{"rendered":"http:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/penn-researchers-explain-how-ends-of-chromosomes-are-maintained-for-cancer-cell-immortality\/"},"modified":"2014-09-26T10:41:46","modified_gmt":"2014-09-26T14:41:46","slug":"penn-researchers-explain-how-ends-of-chromosomes-are-maintained-for-cancer-cell-immortality","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/immortality-medicine\/penn-researchers-explain-how-ends-of-chromosomes-are-maintained-for-cancer-cell-immortality\/","title":{"rendered":"Penn Researchers Explain How Ends of Chromosomes are Maintained for Cancer Cell Immortality"},"content":{"rendered":"<p><p>    PHILADELPHIA  Maintaining the ends of chromosomes, called    telomeres, is a requisite feature of cells that are able to    continuously divide and also a hallmark of human cancer.    Telomeres are much like the plastic cap on the ends of    shoelaces -- they keep the ends of DNA from fraying, says        Roger Greenberg, MD, PhD, associate    professor of Cancer Biology in the Perelman School of    Medicine at the University of    Pennsylvania. In a new study published    this week in Cell, he and his colleagues describe a    mechanism for how cancer cells take over one of the processes    for telomere maintenance to gain an infinite lifespan.  <\/p>\n<p>    Telomeres stay intact in most cancer cell types by means of a    specialized enzyme called telomerase that adds the repetitive    telomere DNA sequences to the ends of chromosomes. Cancer cells    can also use a second method involving a DNA-repair-based    mechanism, called alternative lengthening of telomeres, or ALT    for short. In general, cancer cells take over either type of    telomere maintenance machinery to become immortal. Overall,    approximately fifteen percent of cancers use the ALT process    for telomere lengthening, but some cancer types use ALT up to    40 to 50 percent of the time.  <\/p>\n<p>    Greenbergs co-authors of the new findings are Nam Woo    Cho and Robert L. Dilley, both MD\/PhD    students in his lab, and Michael A. Lampson,    an associate professor of Biology at Penn. Greenberg is also an    associate investigator at the Abramson Family Cancer Research    Institute and director of Basic Science for the Basser Research    Center for BRCA.  <\/p>\n<p>    The team showed that when DNA breaks, it triggers DNA repair    proteins like the breast cancer suppressor protein BRCA2 into    action, along with other helper proteins, that attach to the    damaged stretch of DNA. These proteins stretch out the DNA,    allowing it to search for complementary sequences of telomere    DNA. Breast cancer is linked to mutations in the BRCA1    and BRCA2 genes and mutations in several genes    involved in BRCA-related pathways have also been    associated with breast cancer susceptibility. Breast and    ovarian cancers are associated with a breakdown in the DNA    repair systems involving these BRCA and other related proteins.  <\/p>\n<p>    This process of repair triggers the movement and clustering of    telomeres like fish being reeled toward an angler, explains    Greenberg. The broken telomeres use a telomere on a different    chromosome  the homologous telomere -- as a template for    repair. In fact, in cancer cells that use ALT to maintain    their telomeres, the team could visualize this process by    imaging these clusters of telomeres coming together.  <\/p>\n<p>    We are very excited about the data as it has provided    new insights into this mechanism of telomere maintenance and    ways to think about BRCA dependent and independent DNA    recombination, he says. But, as with most scientific studies,    many more questions are raised than answers provided.  <\/p>\n<p>    The team would like to find other proteins involved in ALT and    look for small molecule drugs that target this telomere    maintenance mechanism in cancer cells to selectively kill    cancer types that use ALT.  <\/p>\n<p>    This study was funded by the National Cancer Institute    (CA13885, CA17494), the National Institute for General Medical    Sciences (GM101149), the Abramson Cancer Research Institute,    and the Basser Research Center for BRCA.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See original here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.uphs.upenn.edu\/news\/News_Releases\/2014\/09\/greenberg\" title=\"Penn Researchers Explain How Ends of Chromosomes are Maintained for Cancer Cell Immortality\">Penn Researchers Explain How Ends of Chromosomes are Maintained for Cancer Cell Immortality<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> PHILADELPHIA Maintaining the ends of chromosomes, called telomeres, is a requisite feature of cells that are able to continuously divide and also a hallmark of human cancer. Telomeres are much like the plastic cap on the ends of shoelaces -- they keep the ends of DNA from fraying, says Roger Greenberg, MD, PhD, associate professor of Cancer Biology in the Perelman School of Medicine at the University of Pennsylvania. In a new study published this week in Cell, he and his colleagues describe a mechanism for how cancer cells take over one of the processes for telomere maintenance to gain an infinite lifespan.  <a href=\"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/immortality-medicine\/penn-researchers-explain-how-ends-of-chromosomes-are-maintained-for-cancer-cell-immortality\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-39351","post","type-post","status-publish","format-standard","hentry","category-immortality-medicine"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/39351"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=39351"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/39351\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=39351"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=39351"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=39351"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}